Giuseppe Ciaramella - Oct 20, 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
President and CSO
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Oct 20, 2023
Transactions value $
$60,903
Form type
4
Date filed
10/24/2023, 04:05 PM
Previous filing
Jul 25, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $60.9K +90.9K +188.39% $0.67* 139K Oct 20, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -90.9K -60.24% $0.00 60K Oct 20, 2023 Common Stock 90.9K $0.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this stock option vested 25% on the first anniversary of the vesting commencement date, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter.